Immunoplex breast cancer immunotherapy (Memcine Pharmaceuticals)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameImmunoplex breast cancer immunotherapy (Memcine Pharmaceuticals)
Drug Alias NameDanuPlex vaccine program (Memcine Pharmaceuticals)
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMemcine Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMemcine Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A